0 Beoordelingen
ID

43316

Beschrijving

ODM derived from http://clinicaltrials.gov/show/NCT01369342

Link

http://clinicaltrials.gov/show/NCT01369342

Trefwoorden

Versies (2)
  1. 11/4/13 11/4/13 - Martin Dugas
  2. 20/9/21 20/9/21 -
Geüploaded op

20 de septiembre de 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    Eligibility NCT01369342 Crohn's Disease

    Duits Engels

    Eligibility

    1 Formulieren  
    1. StudyEvent: Eligibility
      1. Eligibility
    Inclusion Criteria
    Beschrijving

    Inclusion Criteria

    age at least 18 Years
    Beschrijving

    age at least 18 Years

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C0001779 (Age)
    SNOMED
    424144002
    LOINC
    LP28815-6
    SNOMED CT 2011_0131
    397669002 (undefined)
    Have Crohn's disease of at least 3 months' duration with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, or endoscopy
    Beschrijving

    Have Crohn's disease of at least 3 months' duration with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, or endoscopy

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C0010346 (Crohn Disease)
    SNOMED
    34000006
    SNOMED CT 2011_0131
    34000006 (undefined)
    MedDRA 14.1
    10011401 (undefined)
    ICD-10-CM Version 2010
    K50.9 (undefined)
    UMLS CUI 2011AA
    C0011900 (Diagnosis)
    SNOMED
    439401001
    LOINC
    LP30831-9
    SNOMED CT 2011_0131
    439401001 (undefined)
    LOINC Version 232
    MTHU008876 (undefined)
    UMLS CUI 2011AA
    C0009319 (Colitis)
    SNOMED
    64226004
    SNOMED CT 2011_0131
    64226004 (undefined)
    MedDRA 14.1
    10009887 (undefined)
    ICD-10-CM Version 2010
    K52.9 (undefined)
    CTCAE 1105E
    E10521 (undefined)
    UMLS CUI 2011AA
    C0020877 (Ileitis)
    SNOMED
    52457000
    SNOMED CT 2011_0131
    52457000 (undefined)
    MedDRA 14.1
    10021312 (undefined)
    ICD-10-CM Version 2010
    K52.9 (undefined)
    UMLS CUI 2011AA
    C0949272 (IIeocolitis)
    MedDRA 14.1
    10062647 (undefined)
    UMLS CUI 2011AA
    C0750484 (Confirmation)
    LOINC
    LA15290-2
    UMLS CUI 2011AA
    C0043299 (Diagnostic radiologic examination)
    SNOMED
    363680008
    SNOMED CT 2011_0131
    363680008 (undefined)
    ICD-9-CM Version 2011
    87 (undefined)
    UMLS CUI 2011AA
    C0344441 (Histology Procedure)
    SNOMED
    714797009
    LOINC
    LP72693-2
    MedDRA 14.1
    10062005 (undefined)
    LOINC Version 232
    MTHU010496 (undefined)
    UMLS CUI 2011AA
    C0014245 (Endoscopy (procedure))
    SNOMED
    423827005
    LOINC
    LP6254-9
    SNOMED CT 2011_0131
    423827005 (undefined)
    MedDRA 14.1
    10014805 (undefined)
    LOINC Version 232
    MTHU008659 (undefined)
    Have active Crohn's disease, defined as a baseline Crohn Disease Activity Index (CDAI) score of >= 220 and <= 450, with confirmation of active inflammation
    Beschrijving

    Have active Crohn's disease, defined as a baseline Crohn Disease Activity Index (CDAI) score of >= 220 and <= 450, with confirmation of active inflammation

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C0205177 (Active)
    SNOMED
    55561003
    LOINC
    LA16666-2
    SNOMED CT 2011_0131
    55561003 (undefined)
    UMLS CUI 2011AA
    C0010346 (Crohn Disease)
    SNOMED
    34000006
    SNOMED CT 2011_0131
    34000006 (undefined)
    MedDRA 14.1
    10011401 (undefined)
    ICD-10-CM Version 2010
    K50.9 (undefined)
    UMLS CUI 2011AA
    C1704788 (Definition)
    UMLS CUI 2011AA
    C1442488 (Baseline)
    LOINC
    LA16758-7
    UMLS CUI 2011AA
    C0451071 (Crohn's disease activity index)
    SNOMED
    273364009
    SNOMED CT 2011_0131
    273364009 (undefined)
    UMLS CUI 2011AA
    C0449820 (Score)
    SNOMED
    246262008
    LOINC
    MTHU024701
    SNOMED CT 2011_0131
    246262008 (undefined)
    LOINC Version 232
    MTHU024701 (undefined)
    UMLS CUI 2011AA
    C0205177 (Active)
    SNOMED
    55561003
    LOINC
    LA16666-2
    SNOMED CT 2011_0131
    55561003 (undefined)
    UMLS CUI 2011AA
    C0021368 (Inflammation)
    SNOMED
    257552002
    LOINC
    LA7447-1
    SNOMED CT 2011_0131
    23583003 (undefined)
    MedDRA 14.1
    10061218 (undefined)
    Has failed conventional therapy as demonstrated by having received corticosteroids and/or immunomodulators(ie, AZA, MTX, or 6-MP) at adequate therapeutic doses OR Have a history of failure to respond to or tolerate an adequate course of corticosteroids and/or immunomodulators (ie, AZA, MTX, or 6-MP) at adequate therapeutic doses OR Is corticosteroid dependent or has had a history of corticosteroid dependency AND Has not previously demonstrated failure of or intolerance to 1 or more TNF-antagonist therapies (ie, infliximab, adalimumab, or certolizumab pegol) per study criteria
    Beschrijving

    Has failed conventional therapy as demonstrated by having received corticosteroids and/or immunomodulators(ie, AZA, MTX, or 6-MP) at adequate therapeutic doses OR Have a history of failure to respond to or tolerate an adequate course of corticosteroids and/or immunomodulators (ie, AZA, MTX, or 6-MP) at adequate therapeutic doses OR Is corticosteroid dependent or has had a history of corticosteroid dependency AND Has not previously demonstrated failure of or intolerance to 1 or more TNF-antagonist therapies (ie, infliximab, adalimumab, or certolizumab pegol) per study criteria

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C0231175 (Failed)
    UMLS CUI 2011AA
    CL429695 (undefined)
    UMLS CUI 2011AA
    C0001617 (Adrenal Cortex Hormones)
    SNOMED
    21568003
    LOINC
    LP20687-7
    SNOMED CT 2011_0131
    79440004 (undefined)
    UMLS CUI 2011AA
    C1527392 (Immunomodulators)
    SNOMED
    372558009
    SNOMED CT 2011_0131
    108940007 (undefined)
    UMLS CUI 2011AA
    C0004482 (azathioprine)
    SNOMED
    111165009
    SNOMED CT 2011_0131
    372574004 (undefined)
    LOINC Version 232
    MTHU006794 (undefined)
    UMLS CUI 2011AA
    C0025677 (methotrexate)
    SNOMED
    68887009
    SNOMED CT 2011_0131
    387381009 (undefined)
    LOINC Version 232
    MTHU005020 (undefined)
    UMLS CUI 2011AA
    C0000618 (mercaptopurine)
    SNOMED
    1039008
    SNOMED CT 2011_0131
    386835005 (undefined)
    LOINC Version 232
    MTHU002562 (undefined)
    UMLS CUI 2011AA
    C1518422 (Negation)
    LOINC
    LA21291-2
    UMLS CUI 2011AA
    C0162643 (treatment failure)
    MedDRA 14.1
    10066901 (undefined)
    UMLS CUI 2011AA
    C1456820 (Tumor Necrosis Factor-alpha)
    SNOMED
    8612007
    SNOMED CT 2011_0131
    39525005 (undefined)
    LOINC Version 232
    MTHU004497 (undefined)
    UMLS CUI 2011AA
    C0243076 (antagonists)
    UMLS CUI 2011AA
    C0666743 (infliximab)
    SNOMED
    108675009
    SNOMED CT 2011_0131
    386891004 (undefined)
    LOINC Version 232
    MTHU018219 (undefined)
    UMLS CUI 2011AA
    C1122087 (adalimumab)
    SNOMED
    398728003
    SNOMED CT 2011_0131
    407317001 (undefined)
    UMLS CUI 2011AA
    C1172157 (CDP870)
    SNOMED CT 2011_0131
    430307008 (undefined)
    Have screening laboratory test results within protocol-specified parameters
    Beschrijving

    Have screening laboratory test results within protocol-specified parameters

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C1409616 (Special screening finding)
    UMLS CUI 2011AA
    C0587081 (Laboratory test finding)
    SNOMED
    118246004
    SNOMED CT 2011_0131
    118246004 (undefined)
    UMLS CUI 2011AA
    C0332285 (Within)
    SNOMED
    18720000
    SNOMED CT 2011_0131
    18720000 (undefined)
    UMLS CUI 2011AA
    C2348563 (Study Protocol)
    UMLS CUI 2011AA
    C0205369 (Specific qualifier value)
    SNOMED
    69658003
    LOINC
    LP28586-3
    SNOMED CT 2011_0131
    69658003 (undefined)
    UMLS CUI 2011AA
    C0449381 (Observation parameter)
    SNOMED
    252116004
    SNOMED CT 2011_0131
    252116004 (undefined)
    Exclusion Criteria
    Beschrijving

    Exclusion Criteria

    Patients who have had any kind of bowel resection within 6 months
    Beschrijving

    Patients who have had any kind of bowel resection within 6 months

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C1514756 (Receive)
    UMLS CUI 2011AA
    CL407060 (undefined)
    UMLS CUI 2011AA
    C1706124 (Terminology Kind)
    UMLS CUI 2011AA
    C0741614 (Bowel resection)
    MedDRA 14.1
    10067878 (undefined)
    Are pregnant or planning pregnancy (both men and women) while enrolled in the study or for 20 weeks after receiving study agent
    Beschrijving

    Are pregnant or planning pregnancy (both men and women) while enrolled in the study or for 20 weeks after receiving study agent

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C0549206 (Patient currently pregnant)
    SNOMED
    77386006
    LOINC
    LA14670-6
    MedDRA 14.1
    10036586 (undefined)
    UMLS CUI 2011AA
    C0032992 (Pregnancy, Planned)
    SNOMED
    169565003
    SNOMED CT 2011_0131
    169565003 (undefined)
    UMLS CUI 2011AA
    C0025266 (Male population group)
    SNOMED
    339947000
    SNOMED CT 2011_0131
    339947000 (undefined)
    UMLS CUI 2011AA
    C0043210 (Woman)
    SNOMED
    224526002
    SNOMED CT 2011_0131
    224526002 (undefined)
    Patients who have received infliximab, adalimumab or certolizumab pegol < = 8 weeks before the first administration of study drug
    Beschrijving

    Patients who have received infliximab, adalimumab or certolizumab pegol < = 8 weeks before the first administration of study drug

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C1514756 (Receive)
    UMLS CUI 2011AA
    C0666743 (infliximab)
    SNOMED
    108675009
    SNOMED CT 2011_0131
    386891004 (undefined)
    LOINC Version 232
    MTHU018219 (undefined)
    UMLS CUI 2011AA
    C1122087 (adalimumab)
    SNOMED
    398728003
    SNOMED CT 2011_0131
    407317001 (undefined)
    UMLS CUI 2011AA
    C1172157 (CDP870)
    SNOMED CT 2011_0131
    430307008 (undefined)
    UMLS CUI 2011AA
    C0332152 (Before)
    SNOMED
    236874000
    SNOMED CT 2011_0131
    288556008 (undefined)
    UMLS CUI 2011AA
    C1533734 (Administration procedure)
    SNOMED
    416118004
    LOINC
    LA20296-2
    SNOMED CT 2011_0131
    416118004 (undefined)
    UMLS CUI 2011AA
    C0304229 (Experimental drug)
    SNOMED CT 2011_0131
    902003 (undefined)
    Patients with certain complications of Crohn's disease that would make it hard to assess response to study drug
    Beschrijving

    Patients with certain complications of Crohn's disease that would make it hard to assess response to study drug

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C0009566 (Complication)
    SNOMED
    116223007
    SNOMED CT 2011_0131
    116223007 (undefined)
    LOINC Version 232
    MTHU008883 (undefined)
    UMLS CUI 2011AA
    C0010346 (Crohn Disease)
    SNOMED
    34000006
    SNOMED CT 2011_0131
    34000006 (undefined)
    MedDRA 14.1
    10011401 (undefined)
    ICD-10-CM Version 2010
    K50.9 (undefined)
    UMLS CUI 2011AA
    C1299586 (Has difficulty doing (qualifier value))
    SNOMED
    371157007
    SNOMED CT 2011_0131
    52925006 (undefined)
    UMLS CUI 2011AA
    C1516048 (Assessed)
    UMLS CUI 2011AA
    C0871261 (Response process)
    UMLS CUI 2011AA
    C0304229 (Experimental drug)
    SNOMED CT 2011_0131
    902003 (undefined)
    Patients with a history of or ongoing chronic or recurrent infectious disease
    Beschrijving

    Patients with a history of or ongoing chronic or recurrent infectious disease

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C0151317 (Chronic infectious disease)
    SNOMED
    177010002
    SNOMED CT 2011_0131
    177010002 (undefined)
    UMLS CUI 2011AA
    CL429630 (undefined)
    UMLS CUI 2011AA
    C0009450 (Communicable Diseases)
    SNOMED
    189822004
    SNOMED CT 2011_0131
    40733004 (undefined)
    MedDRA 14.1
    10021881 (undefined)
    LOINC Version 232
    MTHU034915 (undefined)
    ICD-9-CM Version 2011
    136.9 (undefined)
    Patients who have previously received a biologic agent targeting IL-12 or IL-23, including but not limited to ustekinumab (CNTO 1275) or briakinumab (ABT-874)
    Beschrijving

    Patients who have previously received a biologic agent targeting IL-12 or IL-23, including but not limited to ustekinumab (CNTO 1275) or briakinumab (ABT-874)

    Datatype

    boolean

    Alias
    UMLS CUI 2011AA
    C0205156 (Previous)
    SNOMED
    9130008
    LOINC
    LP21061-4
    SNOMED CT 2011_0131
    9130008 (undefined)
    UMLS CUI 2011AA
    C1514756 (Receive)
    UMLS CUI 2011AA
    C0005515 (Biological Factors)
    SNOMED
    115668003
    UMLS CUI 2011AA
    C1521840 (Target)
    UMLS CUI 2011AA
    C0123759 (interleukin-12)
    SNOMED
    6411000
    SNOMED CT 2011_0131
    6411000 (undefined)
    LOINC Version 232
    MTHU003527 (undefined)
    UMLS CUI 2011AA
    C0963088 (interleukin-23)
    UMLS CUI 2011AA
    C0332257 (Including (qualifier))
    SNOMED
    55919000
    SNOMED CT 2011_0131
    55919000 (undefined)
    UMLS CUI 2011AA
    C1608841 (ustekinumab)
    SNOMED
    443465002
    SNOMED CT 2011_0131
    443644001 (undefined)
    UMLS CUI 2011AA
    C2744325 (briakinumab)
    Terug naar het begin van de pagina

    Similar models

    Eligibility

    1 Formulieren
    1. StudyEvent: Eligibility
      1. Eligibility
    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    Inclusion Criteria
    age at least 18 Years
    Item
    age at least 18 Years
    boolean
    C0001779 (UMLS CUI 2011AA)
    397669002 (SNOMED CT 2011_0131)
    Have Crohn's disease of at least 3 months' duration with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, or endoscopy
    Item
    Have Crohn's disease of at least 3 months' duration with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, or endoscopy
    boolean
    C0010346 (UMLS CUI 2011AA)
    34000006 (SNOMED CT 2011_0131)
    10011401 (MedDRA 14.1)
    K50.9 (ICD-10-CM Version 2010)
    C0011900 (UMLS CUI 2011AA)
    439401001 (SNOMED CT 2011_0131)
    MTHU008876 (LOINC Version 232)
    C0009319 (UMLS CUI 2011AA)
    64226004 (SNOMED CT 2011_0131)
    10009887 (MedDRA 14.1)
    K52.9 (ICD-10-CM Version 2010)
    E10521 (CTCAE 1105E)
    C0020877 (UMLS CUI 2011AA)
    52457000 (SNOMED CT 2011_0131)
    10021312 (MedDRA 14.1)
    K52.9 (ICD-10-CM Version 2010)
    C0949272 (UMLS CUI 2011AA)
    10062647 (MedDRA 14.1)
    C0750484 (UMLS CUI 2011AA)
    C0043299 (UMLS CUI 2011AA)
    363680008 (SNOMED CT 2011_0131)
    87 (ICD-9-CM Version 2011)
    C0344441 (UMLS CUI 2011AA)
    10062005 (MedDRA 14.1)
    MTHU010496 (LOINC Version 232)
    C0014245 (UMLS CUI 2011AA)
    423827005 (SNOMED CT 2011_0131)
    10014805 (MedDRA 14.1)
    MTHU008659 (LOINC Version 232)
    Have active Crohn's disease, defined as a baseline Crohn Disease Activity Index (CDAI) score of >= 220 and <= 450, with confirmation of active inflammation
    Item
    Have active Crohn's disease, defined as a baseline Crohn Disease Activity Index (CDAI) score of >= 220 and <= 450, with confirmation of active inflammation
    boolean
    C0205177 (UMLS CUI 2011AA)
    55561003 (SNOMED CT 2011_0131)
    C0010346 (UMLS CUI 2011AA)
    34000006 (SNOMED CT 2011_0131)
    10011401 (MedDRA 14.1)
    K50.9 (ICD-10-CM Version 2010)
    C1704788 (UMLS CUI 2011AA)
    C1442488 (UMLS CUI 2011AA)
    C0451071 (UMLS CUI 2011AA)
    273364009 (SNOMED CT 2011_0131)
    C0449820 (UMLS CUI 2011AA)
    246262008 (SNOMED CT 2011_0131)
    MTHU024701 (LOINC Version 232)
    C0205177 (UMLS CUI 2011AA)
    55561003 (SNOMED CT 2011_0131)
    C0021368 (UMLS CUI 2011AA)
    23583003 (SNOMED CT 2011_0131)
    10061218 (MedDRA 14.1)
    Has failed conventional therapy as demonstrated by having received corticosteroids and/or immunomodulators(ie, AZA, MTX, or 6-MP) at adequate therapeutic doses OR Have a history of failure to respond to or tolerate an adequate course of corticosteroids and/or immunomodulators (ie, AZA, MTX, or 6-MP) at adequate therapeutic doses OR Is corticosteroid dependent or has had a history of corticosteroid dependency AND Has not previously demonstrated failure of or intolerance to 1 or more TNF-antagonist therapies (ie, infliximab, adalimumab, or certolizumab pegol) per study criteria
    Item
    Has failed conventional therapy as demonstrated by having received corticosteroids and/or immunomodulators(ie, AZA, MTX, or 6-MP) at adequate therapeutic doses OR Have a history of failure to respond to or tolerate an adequate course of corticosteroids and/or immunomodulators (ie, AZA, MTX, or 6-MP) at adequate therapeutic doses OR Is corticosteroid dependent or has had a history of corticosteroid dependency AND Has not previously demonstrated failure of or intolerance to 1 or more TNF-antagonist therapies (ie, infliximab, adalimumab, or certolizumab pegol) per study criteria
    boolean
    C0231175 (UMLS CUI 2011AA)
    CL429695 (UMLS CUI 2011AA)
    C0001617 (UMLS CUI 2011AA)
    79440004 (SNOMED CT 2011_0131)
    C1527392 (UMLS CUI 2011AA)
    108940007 (SNOMED CT 2011_0131)
    C0004482 (UMLS CUI 2011AA)
    372574004 (SNOMED CT 2011_0131)
    MTHU006794 (LOINC Version 232)
    C0025677 (UMLS CUI 2011AA)
    387381009 (SNOMED CT 2011_0131)
    MTHU005020 (LOINC Version 232)
    C0000618 (UMLS CUI 2011AA)
    386835005 (SNOMED CT 2011_0131)
    MTHU002562 (LOINC Version 232)
    C1518422 (UMLS CUI 2011AA)
    C0162643 (UMLS CUI 2011AA)
    10066901 (MedDRA 14.1)
    C1456820 (UMLS CUI 2011AA)
    39525005 (SNOMED CT 2011_0131)
    MTHU004497 (LOINC Version 232)
    C0243076 (UMLS CUI 2011AA)
    C0666743 (UMLS CUI 2011AA)
    386891004 (SNOMED CT 2011_0131)
    MTHU018219 (LOINC Version 232)
    C1122087 (UMLS CUI 2011AA)
    407317001 (SNOMED CT 2011_0131)
    C1172157 (UMLS CUI 2011AA)
    430307008 (SNOMED CT 2011_0131)
    Have screening laboratory test results within protocol-specified parameters
    Item
    Have screening laboratory test results within protocol-specified parameters
    boolean
    C1409616 (UMLS CUI 2011AA)
    C0587081 (UMLS CUI 2011AA)
    118246004 (SNOMED CT 2011_0131)
    C0332285 (UMLS CUI 2011AA)
    18720000 (SNOMED CT 2011_0131)
    C2348563 (UMLS CUI 2011AA)
    C0205369 (UMLS CUI 2011AA)
    69658003 (SNOMED CT 2011_0131)
    C0449381 (UMLS CUI 2011AA)
    252116004 (SNOMED CT 2011_0131)
    Item Group
    Exclusion Criteria
    Patients who have had any kind of bowel resection within 6 months
    Item
    Patients who have had any kind of bowel resection within 6 months
    boolean
    C1514756 (UMLS CUI 2011AA)
    CL407060 (UMLS CUI 2011AA)
    C1706124 (UMLS CUI 2011AA)
    C0741614 (UMLS CUI 2011AA)
    10067878 (MedDRA 14.1)
    Are pregnant or planning pregnancy (both men and women) while enrolled in the study or for 20 weeks after receiving study agent
    Item
    Are pregnant or planning pregnancy (both men and women) while enrolled in the study or for 20 weeks after receiving study agent
    boolean
    C0549206 (UMLS CUI 2011AA)
    10036586 (MedDRA 14.1)
    C0032992 (UMLS CUI 2011AA)
    169565003 (SNOMED CT 2011_0131)
    C0025266 (UMLS CUI 2011AA)
    339947000 (SNOMED CT 2011_0131)
    C0043210 (UMLS CUI 2011AA)
    224526002 (SNOMED CT 2011_0131)
    Patients who have received infliximab, adalimumab or certolizumab pegol < = 8 weeks before the first administration of study drug
    Item
    Patients who have received infliximab, adalimumab or certolizumab pegol < = 8 weeks before the first administration of study drug
    boolean
    C1514756 (UMLS CUI 2011AA)
    C0666743 (UMLS CUI 2011AA)
    386891004 (SNOMED CT 2011_0131)
    MTHU018219 (LOINC Version 232)
    C1122087 (UMLS CUI 2011AA)
    407317001 (SNOMED CT 2011_0131)
    C1172157 (UMLS CUI 2011AA)
    430307008 (SNOMED CT 2011_0131)
    C0332152 (UMLS CUI 2011AA)
    288556008 (SNOMED CT 2011_0131)
    C1533734 (UMLS CUI 2011AA)
    416118004 (SNOMED CT 2011_0131)
    C0304229 (UMLS CUI 2011AA)
    902003 (SNOMED CT 2011_0131)
    Patients with certain complications of Crohn's disease that would make it hard to assess response to study drug
    Item
    Patients with certain complications of Crohn's disease that would make it hard to assess response to study drug
    boolean
    C0009566 (UMLS CUI 2011AA)
    116223007 (SNOMED CT 2011_0131)
    MTHU008883 (LOINC Version 232)
    C0010346 (UMLS CUI 2011AA)
    34000006 (SNOMED CT 2011_0131)
    10011401 (MedDRA 14.1)
    K50.9 (ICD-10-CM Version 2010)
    C1299586 (UMLS CUI 2011AA)
    52925006 (SNOMED CT 2011_0131)
    C1516048 (UMLS CUI 2011AA)
    C0871261 (UMLS CUI 2011AA)
    C0304229 (UMLS CUI 2011AA)
    902003 (SNOMED CT 2011_0131)
    Patients with a history of or ongoing chronic or recurrent infectious disease
    Item
    Patients with a history of or ongoing chronic or recurrent infectious disease
    boolean
    C0151317 (UMLS CUI 2011AA)
    177010002 (SNOMED CT 2011_0131)
    CL429630 (UMLS CUI 2011AA)
    C0009450 (UMLS CUI 2011AA)
    40733004 (SNOMED CT 2011_0131)
    10021881 (MedDRA 14.1)
    MTHU034915 (LOINC Version 232)
    136.9 (ICD-9-CM Version 2011)
    Patients who have previously received a biologic agent targeting IL-12 or IL-23, including but not limited to ustekinumab (CNTO 1275) or briakinumab (ABT-874)
    Item
    Patients who have previously received a biologic agent targeting IL-12 or IL-23, including but not limited to ustekinumab (CNTO 1275) or briakinumab (ABT-874)
    boolean
    C0205156 (UMLS CUI 2011AA)
    9130008 (SNOMED CT 2011_0131)
    C1514756 (UMLS CUI 2011AA)
    C0005515 (UMLS CUI 2011AA)
    C1521840 (UMLS CUI 2011AA)
    C0123759 (UMLS CUI 2011AA)
    6411000 (SNOMED CT 2011_0131)
    MTHU003527 (LOINC Version 232)
    C0963088 (UMLS CUI 2011AA)
    C0332257 (UMLS CUI 2011AA)
    55919000 (SNOMED CT 2011_0131)
    C1608841 (UMLS CUI 2011AA)
    443644001 (SNOMED CT 2011_0131)
    C2744325 (UMLS CUI 2011AA)
    Terug naar het begin van de pagina 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial